Abstract
The first influenza pandemic in over 40 years was caused by a novel influenza A strain, A(H1N1)pdm09. Fortunately, most of those infected suffered mild disease. However, a significant minority of young adults and children exhibited severe illness, sometimes resulting in respiratory failure and even death. In the UK, A(H1N1)pdm09 influenza also caused a large disease burden the post-pandemic winter of 2010/11, stretching some healthcare resources to the limit. Although some pre-existing conditions increased the risk of severe disease, pregnant women and those with no underlying health problems contributed substantially to the total number of hospitalisations. Why outcomes of infection vary so widely is unknown and optimal personalised treatment strategies are yet to be developed. In this review, we give an overview of A(H1N1)pdm09 influenza in adults and the evidence supporting pharmacological interventions, with a focus on the use of antiviral agents.
Keywords: Antiviral, H1N1, influenza, pandemic, treatment, respiratory failure, vaccination, Dyspnoea, chronic obstructive pulmonary disease
Current Respiratory Medicine Reviews
Title:Severe Influenza: Clinical Features and Treatment Options
Volume: 8 Issue: 3
Author(s): Jake Dunning and Peter Openshaw
Affiliation:
Keywords: Antiviral, H1N1, influenza, pandemic, treatment, respiratory failure, vaccination, Dyspnoea, chronic obstructive pulmonary disease
Abstract: The first influenza pandemic in over 40 years was caused by a novel influenza A strain, A(H1N1)pdm09. Fortunately, most of those infected suffered mild disease. However, a significant minority of young adults and children exhibited severe illness, sometimes resulting in respiratory failure and even death. In the UK, A(H1N1)pdm09 influenza also caused a large disease burden the post-pandemic winter of 2010/11, stretching some healthcare resources to the limit. Although some pre-existing conditions increased the risk of severe disease, pregnant women and those with no underlying health problems contributed substantially to the total number of hospitalisations. Why outcomes of infection vary so widely is unknown and optimal personalised treatment strategies are yet to be developed. In this review, we give an overview of A(H1N1)pdm09 influenza in adults and the evidence supporting pharmacological interventions, with a focus on the use of antiviral agents.
Export Options
About this article
Cite this article as:
Dunning Jake and Openshaw Peter, Severe Influenza: Clinical Features and Treatment Options, Current Respiratory Medicine Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339812800493223
DOI https://dx.doi.org/10.2174/157339812800493223 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypersensitivity Pneumonitis
Current Pediatric Reviews The Treatment of Autoimmune Hepatitis
Current Clinical Pharmacology The Role of Autophagy in Rheumatic Disease
Current Drug Targets Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Current Hypertension Reviews Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review
Current Pharmaceutical Design Assessments of Immunomodulatory and Inflammatory effects against Induction of Entamoeba histolytica (HM1 IMS strain) crude extract Antigen in Complete Freund’s Adjuvant Induced Rheumatoid Arthritis Female Wistar Rats
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Small Molecules as Anti-TNF Drugs
Current Medicinal Chemistry The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases
Current Medicinal Chemistry Homocysteine, Intracellular Signaling and Thrombotic Disorders
Current Medicinal Chemistry Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis
Current Pharmaceutical Design The Evaluation and Management of Adult-Onset Henoch-Schonlein Purpura
Current Rheumatology Reviews Beneficial Effects of Vildagliptin on Metabolic Parameters in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Mouse Models of Experimental Autoimmune Uveitis: Comparative Analysis of Adjuvant-Induced vs Spontaneous Models of Uveitis
Current Molecular Medicine Lupus Nephritis: Current Treatment Paradigm and Unmet Needs
Reviews on Recent Clinical Trials Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety Predictors of Avascular Necrosis in a Cohort of Egyptian Systemic Lupus Erythematosus Patients: Retrospective Two Centers Study
Current Rheumatology Reviews Autoimmune Neuromuscular Disorders
Current Neuropharmacology General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets (Discontinued) Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis
Current Rheumatology Reviews